237 related articles for article (PubMed ID: 30909873)
1. Urinary angiotensinogen level is associated with potassium homeostasis and clinical outcome in patients with polycystic kidney disease: a prospective cohort study.
Kim H; Park S; Jhee JH; Yun HR; Park JT; Han SH; Lee J; Kim SW; Kim YH; Oh YK; Kang SW; Choi KH; Yoo TH;
BMC Nephrol; 2019 Mar; 20(1):104. PubMed ID: 30909873
[TBL] [Abstract][Full Text] [Related]
2. Urinary Angiotensinogen in addition to Imaging Classification in the Prediction of Renal Outcome in Autosomal Dominant Polycystic Kidney Disease.
Park HC; Kim J; Cho A; Kim DH; Lee YK; Ryu H; Kim H; Oh KH; Oh YK; Hwang YH; Lee KB; Kim SW; Kim YH; Lee J; Ahn C;
J Korean Med Sci; 2020 Jun; 35(22):e165. PubMed ID: 32508065
[TBL] [Abstract][Full Text] [Related]
3. Urinary renin-angiotensin markers in polycystic kidney disease.
Salih M; Bovée DM; Roksnoer LCW; Casteleijn NF; Bakker SJL; Gansevoort RT; Zietse R; Danser AHJ; Hoorn EJ
Am J Physiol Renal Physiol; 2017 Oct; 313(4):F874-F881. PubMed ID: 28747358
[TBL] [Abstract][Full Text] [Related]
4. Increased urinary Angiotensinogen/Creatinine (AGT/Cr) ratio may be associated with reduced renal function in autosomal dominant polycystic kidney disease patients.
Park HC; Kang AY; Jang JY; Kim H; Han M; Oh KH; Kim SH; Noh JW; Cheong HI; Hwang YH; Ahn C
BMC Nephrol; 2015 Jun; 16():86. PubMed ID: 26092580
[TBL] [Abstract][Full Text] [Related]
5. Increased heart rate is associated with intrarenal renin-angiotensin system activation in chronic kidney disease patients.
Ohashi N; Isobe S; Ishigaki S; Aoki T; Matsuyama T; Sato T; Fujikura T; Kato A; Yasuda H
Clin Exp Nephrol; 2019 Sep; 23(9):1109-1118. PubMed ID: 31131423
[TBL] [Abstract][Full Text] [Related]
6. Urinary angiotensinogen as a potential biomarker of intrarenal renin-angiotensin system activity in Chinese chronic kidney disease patients.
Xu Z; Xu B; Xu C
Ir J Med Sci; 2015 Jun; 184(2):297-304. PubMed ID: 24664631
[TBL] [Abstract][Full Text] [Related]
7. ELISA examining urinary angiotensinogen as a potential indicator of intrarenal renin-angiotensin system (RAS) activity: a clinical study of 128 chronic kidney disease patients.
Zhang XY; Ding XQ; Lv WL; Teng J; Zhong YH
Mol Biol Rep; 2013 Oct; 40(10):5817-24. PubMed ID: 24065527
[TBL] [Abstract][Full Text] [Related]
8. Interrelationship between renin-angiotensin-aldosterone system and oxidative stress in chronic heart failure patients with or without renal impairment.
Reina-Couto M; Afonso J; Carvalho J; Morgado L; Ronchi FA; de Oliveira Leite AP; Dias CC; Casarini DE; Bettencourt P; Albino-Teixeira A; Morato M; Sousa T
Biomed Pharmacother; 2021 Jan; 133():110938. PubMed ID: 33171402
[TBL] [Abstract][Full Text] [Related]
9. Urinary renin, but not angiotensinogen or aldosterone, reflects the renal renin-angiotensin-aldosterone system activity and the efficacy of renin-angiotensin-aldosterone system blockade in the kidney.
van den Heuvel M; Batenburg WW; Jainandunsing S; Garrelds IM; van Gool JM; Feelders RA; van den Meiracker AH; Danser AH
J Hypertens; 2011 Nov; 29(11):2147-55. PubMed ID: 21941204
[TBL] [Abstract][Full Text] [Related]
10. Potential role of urinary angiotensinogen in predicting antiproteinuric effects of angiotensin receptor blocker in non-diabetic chronic kidney disease patients: a preliminary report.
Jang HR; Lee YJ; Kim SR; Kim SG; Jang EH; Lee JE; Huh W; Kim YG
Postgrad Med J; 2012 Apr; 88(1038):210-6. PubMed ID: 22357774
[TBL] [Abstract][Full Text] [Related]
11. Intrarenal Renin-Angiotensin System Activation Alters Relationship Between Systolic Blood Pressure and Progression of Chronic Kidney Disease.
Park CH; Kim HW; Park JT; Chang TI; Yoo TH; Lee J; Sung S; Jung JY; Hyun YY; Oh KH; Kang SW; Han SH;
Hypertension; 2023 May; 80(5):1024-1034. PubMed ID: 37075134
[TBL] [Abstract][Full Text] [Related]
12. The effect of ramipril and telmisartan on serum potassium and its association with cardiovascular and renal events: results from the ONTARGET trial.
Heerspink HJ; Gao P; de Zeeuw D; Clase C; Dagenais GR; Sleight P; Lonn E; Teo KT; Yusuf S; Mann JF
Eur J Prev Cardiol; 2014 Mar; 21(3):299-309. PubMed ID: 24191305
[TBL] [Abstract][Full Text] [Related]
13. Vitamin D receptor activation with calcitriol for reducing urinary angiotensinogen in patients with type 2 diabetic chronic kidney disease.
Tiryaki Ö; Usalan C; Sayiner ZA
Ren Fail; 2016; 38(2):222-7. PubMed ID: 26707134
[TBL] [Abstract][Full Text] [Related]
14. Hyperuricaemia is associated with renal damage independently of hypertension and intrarenal renin-angiotensin system activation, as well as their circadian rhythms.
Ohashi N; Ishigaki S; Isobe S; Tsuji N; Iwakura T; Ono M; Tsuji T; Sakao Y; Kato A; Yasuda H
Nephrology (Carlton); 2015 Nov; 20(11):814-9. PubMed ID: 25968901
[TBL] [Abstract][Full Text] [Related]
15. The Urinary Angiotensinogen to Urinary Albumin Ratio Reflects Whether the Renin-angiotensin System in the Kidney Is Activated due to Filtration of Plasma Angiotensinogen through the Damaged Glomeruli or the Production of Angiotensinogen in the Proximal Tubules.
Ohashi N; Aoki T; Matsuyama T; Ishigaki S; Isobe S; Katahashi N; Sato T; Fujikura T; Kato A; Yasuda H
Intern Med; 2020 Feb; 59(3):357-364. PubMed ID: 31534091
[TBL] [Abstract][Full Text] [Related]
16. Urinary angiotensinogen as a surrogate marker predicting the antiproteinuric effects of angiotensin receptor blockers in patients with overt proteinuria: a multicenter prospective study.
Jeon J; Kim DH; Jang HR; Lee JE; Huh W; Kim HY; Kim DJ; Kim YG
BMC Nephrol; 2020 May; 21(1):180. PubMed ID: 32410703
[TBL] [Abstract][Full Text] [Related]
17. Urinary angiotensinogen as a marker of intrarenal angiotensin II activity in adolescents with primary hypertension.
Kuroczycka-Saniutycz E; Wasilewska A; Sulik A; Milewski R
Pediatr Nephrol; 2013 Jul; 28(7):1113-9. PubMed ID: 23529640
[TBL] [Abstract][Full Text] [Related]
18. Chronotherapy with a Renin-angiotensin System Inhibitor Ameliorates Renal Damage by Suppressing Intrarenal Renin-angiotensin System Activation.
Aoki T; Ohashi N; Isobe S; Ishigaki S; Matsuyama T; Sato T; Fujikura T; Kato A; Miyajima H; Yasuda H
Intern Med; 2020; 59(18):2237-2244. PubMed ID: 32938851
[TBL] [Abstract][Full Text] [Related]
19. Evidence of Augmented Intrarenal Angiotensinogen Associated With Glomerular Swelling in Gestational Hypertension and Preeclampsia: Clinical Implications.
Mistry HD; Kurlak LO; Gardner DS; Torffvit O; Hansen A; Broughton Pipkin F; Strevens H
J Am Heart Assoc; 2019 Jul; 8(13):e012611. PubMed ID: 31237175
[TBL] [Abstract][Full Text] [Related]
20. Increased urinary excretion of angiotensinogen is associated with risk of chronic kidney disease.
Mills KT; Kobori H; Hamm LL; Alper AB; Khan IE; Rahman M; Navar LG; Liu Y; Browne GM; Batuman V; He J; Chen J
Nephrol Dial Transplant; 2012 Aug; 27(8):3176-81. PubMed ID: 22399491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
